Form CORRESP - Correspondence:
SEC Accession No. 0001193125-24-151734
Filing Date
2024-05-31
Accepted
2024-05-31 16:05:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 5460
  Complete submission text file 0001193125-24-151734.txt   6701
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Therapeutics, Inc. (Filer) CIK: 0001789972 (see all company filings)

EIN.: 813867811 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)